Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/449291


Emerging Generic Drug Companies Worldwide 2007


Description: The operating environment for medium-sized generic drug manufacturers is changing rapidly as the industry matures and growth focuses on new market opportunities.

Consolidation continues to affect companies, as acquisition becomes the instrument of choice in the drive for market share.

But…
-Who are the medium-sized companies of note?
-How well do they perform?
-What products do they produce?
-Where are they located?

This report will tell you!

Who’s next? The rapidly changing face of the global generics industry…


The pace of corporate consolidation grows ever faster - eight significant acquisitions were announced in 2006:


Andrx/ Watson
Mayne Pharma/ Hospira
Betapharm/ Dr Reddy's
Pliva/ Barr Pharmaceutical
Matrix/ Mylan Labs
Zentiva/sanofi-aventis
Terapia/ Ranbaxy
Hemofarm/ Stada Arzneimittel
Sindan/Actavis

Increasingly the industry is being rationalised and dominated by fewer and fewer large players. Teva and Sandoz may be fighting it out for the top spot but the speed of change is seeing the corporate landscape change continuously.

And what about 2007?
All generic companies are operating in increasingly crowded and competitive environments as far as the traditional high value markets such as the UK and USA are concerned. Focus is switching to growth markets such as France, Spain, Brazil and Italy where significant double-digit growth is forecast to 2011. With business cycles growing shorter and shorter, market entry is quicker and more reliable through acquisition and partnering.

Drivers for change
In addition to ongoing expansion, there are other drivers which are causing the generic companies to consider the future:

-The number of new generic drug opportunities are reducing in line with the decline in NDAs over recent years. Furthermore, the branded industry is far more aware of the potential to protect revenues by issuing early branded generics and/or new formulations.

-The increasing introduction of biotech based products will present regulatory and production hurdles to generic manufacturers in the future.

Identify new business opportunities and assess risk
For everyone needing to evaluate the generic industry’s competitive landscape this new, thoroughly researched 350-page report Emerging Generic Drug Companies Worldwide 2007 (Published February 2007) is essential reading.

For each company where available or appropriate:

BACKGROUND
A summary of the company’s foundation and main business interests

PRODUCT RANGE
Details of ANDAs approved or products represented

FINANCIAL
Financial performance or funding data

STRATEGIC ALLIANCES
Details of significant marketing and supply agreements

CONTACT INFORMATION

Use this report to…

-Identify commercial partners

-Understand the developing generic industry in key markets worldwide

-Profile the competitive environment in the increasingly important medium sized company sector

-Seek out companies manufacturing/marketing similar product lines

-Assess the investment potential of these developing companies


Contents: Introduction 1
Argentina 6
Osmotica Pharmaceutical 6
Background 6
Products 7
Contact Details 7
Australia 8
Australian Pharmaceutical Industries 8
Background 8
Financials 8
Major Developments 9
Contact Details 13
GenePharm Australasia 14
Background 14
Products 14
Major Developments 15
Contact Details 17
Hamilton Laboratories 18
Background 18
Products 18
Contact Details 18
Sigma Pharmaceuticals 19
Background 19
Products 19
Financials 19
Major Developments 20
Contact Details 23
Bangladesh 24
Beximco Pharmaceuticals 24
Background 24
Products 24
Financials 26
Major Developments 26
Contact Details 28
Brazil 29
Aché 29
Background 29
Products 29
Financials 29
Contact Details 29
Biolab 30
Background 30
Contact Details 30
Biosintética 31
Background 31
Products 31
Financials 31
Contact Details 32
Cimed 33
Background 33
Contact Details 33
Cristália 34
Background 34
Contact Details 35
EMS-Sigma 36
Background 36
Contact Details 37
Eurofarma 38
Background 38
Contact Details 38
Farmasa 39
Background 39
Contact Details 39
Libbs Farmacêutica 40
Background 40
Financials 40
Contact Details 40
Medley 41
Background 41
Contact Details 42
Bulgaria 43
Sopharma 43
Background 43
Products 43
Financials 43
Contact Details 44
Unipharm 45
Background 45
Contact Details 45
Canada 46
Labopharm 46
Background 46
Products 46
Financials 47
Major Developments 48
Contact Details 51
Orbus Pharma 52
Background 52
Products 52
Financials 53
Major Developments 54
Contact Details 57
Chile 58
Andrómaco 58
Background 58
Products 58
Financials 59
Major Developments 60
Contact Details 60
Bestpharma 61
Background 61
Contact Details 61
Biosano 62
Background 62
Contact Details 62
Maver 63
Background 63
Contact Details 63
Mintlab 64
Background 64
Contact Details 64
Colombia 65
Ecar 65
Background 65
Contact details 65
Genfar 66
Background 66
Contact Details 66
La Santé 67
Background 67
Contact Details 67
Lafrancol 68
Background 68
Contact Details 68
Costa Rica 69
Laboratorios Stein 69
Background 69
Contact Details 69
Croatia 70
Belupo 70
Background 70
Products 70
Contact Details 71
Denmark 72
Alternova 72
Background 72
Products 72
Contact Details 73
Copyfarm 74
Background 74
Products 74
Contact Details 74
Egypt 75
EIPICo 75
Background 75
Contact Details 75
France 76
Biogaran 76
Background 76
Contact Details 76
India 77
Alembic 77
Background 77
Products 77
Financials 78
Contact Details 79
Aurobindo Pharma 80
Background 80
Products 80
Financials 86
Major Developments 86
Contact Details 88
Biocon 89
Background 89
Products 89
Financials 89
Major Developments 90
Contact Details 91
Glenmark Pharmaceuticals 92
Background 92
Products 92
Financials 95
Major Developments 95
Contact Details 99
JB Chemicals & Pharmaceuticals 100
Background 100
Products 100
Financials 101
Major Developments 101
Contact Details 103
Jubilant Organosys 104
Background 104
Products 104
Financials 104
Major Developments 106
Contact Details 106
Lupin Laboratories 107
Background 107
Products 107
Financials 110
Major Developments 111
Contact Details 113
Matrix Laboratories 114
Background 114
Products 114
Financials 114
Major Developments 115
Contact Details 120
Natco Pharma 121
Background 121
Products 121
Financials 122
Major Developments 123
Contact Details 124
Orchid Chemicals & Pharmaceutials 125
Background 125
Products 125
Financials 127
Major Developments 127
Contact Details 129
Strides Arcolab 130
Background 130
Products 130
Financials 130
Major Developments 131
Contact Details 136
Sun Pharmaceutical Industries 137
Background 137
Products 137
Financials 138
Major Developments 139
Contact Details 141
Indonesia 142
Kimia 142
Background 142
Contact Details 142
Ireland 143
Consilient Health 143
Background 143
Products 143
Contact Details 144
Israel 145
Taro Pharmaceutical Industries 145
Background 145
Products 145
Financials 151
Major Developments 152
Contact Details 153
Italy 154
Eurand 154
Background 154
Products 154
Contact Details 155
Jordan 156
Hikma 156
Background 156
Products 156
Financials 158
Major Developments 162
Contact Details 163
Latvia 164
Grindeks 164
Background 164
Products 164
Financials 164
Major Developments 165
Contact Details 167
Lithuania 168
Sanitas 168
Introduction 168
Background 168
Products 168
Financials 168
Major Developments 170
Contact Details 170
Malaysia 171
Inno Biologics 171
Background 171
Products 171
Contact Details 172
Mexico 173
Laboratorios Kendrick 173
Background 173
Contact Details 173
Laboratorios Silanes 174
Background 174
Contact Details 174
Pakistan 175
CCL 175
Background 175
Contact Details 175
Dr Raza Pharma 176
Background 176
Contact Details 176
Epla Labs 177
Background 177
Contact Details 177
Highnoon Laboratories 178
Background 178
Products 178
Financials 178
Contact Details 178
Peru 179
Farmindustria 179
Background 179
Contact Details 179
Infarmasa 180
Background 180
Financials 180
Contact Details 180
Portugal 181
Hovione FarmaCiencia 181
Background 181
Products 181
Financials 182
Major Developments 182
Contact Details 184
Romania 185
Antibiotice 185
Background 185
Products 185
Contact Details 186
Europharm 187
Background 187
Contact Details 187
Russia 188
Akrikhin 188
Background 188
Products 188
Contact Details 188
Bryntsalov A 189
Background 189
Erka Farm 190
Background 190
Farmacon 191
Background 191
Contact Details 191
Veropharm 192
Background 192
Contact Details 192
Saudi Arabia 193
Tabuk Pharmaceutical Manufacturing 193
Background 193
Contact Details 193
Slovakia 194
Biotika 194
Background 194
Financials 194
Contact Details 194
South Africa 195
Adcock Ingram 195
Background 195
Products 195
Major Developments 196
Contact Details 196
Enaleni Pharmaceuticals 197
Background 197
Products 197
Financials 198
Major Developments 199
Contact Details 201
Sweden 202
Recip 202
Background 202
Products 202
Financials 202
Contact Details 203
Switzerland 204
Mepha Pharma 204
Background 204
Contact Details 205
Spirig 206
Background 206
Products 206
Contact Details 206
Streuli 207
Background 207
Contact Details 207
Turkey 208
Abdi Ibrahim 208
Background 208
Products 208
Major Developments 209
Contact Details 209
Bilim Pharmaceuticals 210
Background 210
Products 210
Contact Details 210
MN Pharmaceuticals 211
Background 211
Products 211
Major Developments 211
Contact Details 212
UK 213
GeneMedix 213
Background 213
Products 213
Financials 213
Major Developments 215
Contact Details 219
Goldshield Group 220
Background 220
Products 220
Financials 220
Major Developments 222
Contact Details 223
Kent Pharmaceuticals 224
Background 224
Major Developments 224
Contact Details 225
ProStrakan 226
Background 226
Products 226
Financials 228
Major Developments 228
Contact Details 230
Rosemont Pharmaceutical 231
Background 231
Products 231
Major Developments 231
Contact Details 232
USA 233
Abraxis BioScience 233
Background 233
Products 233
Financials 238
Major Developments 239
Contact Details 239
Abrika Pharmaceuticals 240
Background 240
Products 240
Major Developments 241
Contact Details 242
Akorn 243
Background 243
Products 243
Financials 244
Major Developments 245
Contact Details 250
Akyma Pharmaceuticals 251
Background 251
Products 251
Contact Details 252
Amphastar Pharmaceuticals 253
Background 253
Products 253
Major Developments 254
Contact Details 255
Banner Pharmacaps 256
Background 256
Products 256
Contact Details 256
Bedford Laboratories 257
Background 257
Products 257
Contact Details 260
Bentley Pharmaceuticals 261
Background 261
Products 261
Financials 263
Major Developments 264
Contact Details 266
Bio-Nucleonics 267
Background 267
Products 267
Contact Details 267
Boca Pharmacal 268
Background 268
Products 268
Contact Details 268
Caraco Pharmacutical Laboratories 269
Background 269
Products 269
Financials 271
Major Developments 272
Contact Details 272
Carolina Medical Products Company 273
Background 273
Products 273
Contact Details 273
Cedar Pharmaceuticals 274
Background 274
Products 274
Contact Details 274
Cedarburg Pharmaceuticals 275
Background 275
Products 275
Contact Details 275
CorePharma 276
Background 276
Products 276
Major Developments 277
Contact Details 277
Ferndale Laboratories 278
Background 278
Products 278
Contact Details 278
Fleming & Company Pharmaceuticals 279
Background 279
Products 279
Contact Details 279
Fougera 280
Background 280
Products 280
Major Developments 282
Contact Details 282
G&W Laboratories 283
Background 283
Products 283
Contact Details 283
Glades Pharmaceuticals 284
Background 284
Products 284
Contact Details 284
GC Hanford Manufacturing 285
Background 285
Products 285
Contact Details 285
Harmony Labs 286
Background 286
Products 286
Contact Details 286
Hi-Tech Pharmacal 287
Background 287
Products 287
Financials 289
Major Developments 289
Contact Details 290
Impax Laboratories 291
Background 291
Products 291
Financials 295
Major Developments 296
Contact Details 300
Interpharm 301
Background 301
Products 301
Financials 302
Major Developments 303
Contact Details 304
InvaGen Pharmaceuticals 305
Background 305
Products 305
Major Developments 305
Contact Details 306
Kremers Urban Development Company (KUDCo) 307
Background 307
Products 307
Major Developments 307
Contact Details 308
KV Pharmaceutical 309
Background 309
Products 309
Financials 310
Major Developments 311
Contact Details 312
Luitpold Pharmaceuticals 313
Background 313
Products 313
Contact Details 314
Lyne Laboratories 315
Background 315
Products 315
Contact Details 315
Mallinckrodt 316
Background 316
Products 316
Major Developments 317
Contact Details 317
Mikart 318
Background 318
Products 318
Contact Details 318
Morton Grove Pharmaceuticals 319
Background 319
Products 319
Major Developments 320
Contact Details 320
Neil Laboratories 321
Background 321
Products 321
Contact Details 321
Nephron Pharmaceuticals 322
Background 322
Products 322
Contact Details 322
Paddock Laboratories 323
Background 323
Products 323
Contact Details 323
Parenta Pharmaceuticals 324
Background 324
Products 324
Major Developments 324
Contact Details 325
Pharmaceutical Associates 326
Background 326
Products 326
Contact Details 326
Prometheus Laboratories 327
Background 327
Products 327
Contact Details 327
Roxane Laboratories 328
Background 328
Products 328
Financials 329
Contact Details 329
RxElite 330
Background 330
Products 330
Contact Details 330
Silarx Pharmaceuticals 331
Background 331
Products 331
Contact Details 331
Spear Pharmaceuticals 332
Background 332
Products 332
Contact Details 332
Spectrum Pharmaceuticals 333
Background 333
Products 333
Financials 334
Major Developments 335
Contact Details 337
Stiefel 338
Background 338
Products 338
Contact Details 338
SuperGen 339
Background 339
Products 339
Contact Details 339
Three Rivers Pharmaceuticals 340
Background 340
Products 340
Major Developments 341
Contact Details 342
United Research Laboratories / Mutual Pharmaceutical Company 343
Background 343
Products 343
Contact Details 348
Upsher-Smith Laboratories 349
Background 349
Products 349
Major Developments 350
Contact Details 354
Vista Pharmaceuticals 355
Background 355
Products 355
Contact Details 355
VistaPharm 356
Background 356
Products 356
Contact Details 356
X-GEN Pharmaceuticals 357
Background 357
Products 357
Major Developments 357
Contact Details 358
Venezuela 359
Calox Internacional 359
Background 359
Contact Details 359
Cofasa 360
Background 360
Contact Details 360
Elter 361
Background 361
Contact Details 361
Kimiceg 362
Background 362
Contact Details 362
Leti 363
Background 363
Contact Details 363
Meyer 364
Background 364
Contact Details 364

INDEX OF TABLES
Companies in the report by country of origin 1
Osmotica Pharmaceutical ANDA Approvals, 2002-06 7
Libbs’ Pharmaceutical Sales, 2000-2004 40
Medley’s International Agreements, 1992-2005 41
Sopharma Financial Data, 1999-2004 (Leva 000s) 43
Aurobindo Pharma ANDA Approvals, 2002-06 82
Glenmark Pharmaceuticals ANDA Approvals, 2002-06 92
Unique Pharmaceutical Laboratories ANDA Approvals, 2002-06 100
Trigen Laboratories / Jubilant Pharmaceuticals ANDA Approvals, 2002-06 104
Lupin Laboratories ANDA Approvals, 2002-06 108
Orchid Healthcare ANDA Approvals, 2002-06 125
Sun Pharmaceutical Laboratories ANDA Approvals, 2002-06 138
Taro Pharmaceutical Industries ANDA Approvals, 2002-06 146
Eurand ANDA Approvals, 2002-06 154
Hikma: 2005 filings 156
Hikma Pharmaceuticals ANDA Approvals, 2002-06 157
Hikma Farmacêutica ANDA Approvals, 2002-06 157
West-Ward ANDA Approvals, 2002-06 158
Hikma: 2005 Results (US$ millions) 160
Hikma: 2005 Results by Geography (US$ millions) 160
Recip ANDA Approvals, 2002-06 202
Price Comparison Between Mepha Generics and Originators for Selected Leading Drugs 204
American Pharmaceutical Partners/Abraxis Pharmaceutical Products ANDA Approvals, 2002-06234
Abrika Pharmaceuticals ANDA Approvals, 2002-06 240
Akorn ANDA Approvals, 2002-06 243
Akyma Pharmaceuticals ANDA Approvals, 2002-06 251
Amphastar Pharmaceuticals ANDA Approvals, 2002-06 253
International Medication Systems ANDA Approvals, 2002-06 253
Banner Pharmacaps ANDA Approvals, 2002-06 256
Bedford Laboratories ANDA Approvals, 2002-06 257
Ben Venue Laboratories ANDA Approvals, 2002-06 258
Bio-Nucleonics ANDA Approvals, 2002-06 267
Boca Pharmacal ANDA Approvals, 2002-06 268
Caraco Pharmaceutical Laboratories ANDA Approvals, 2002-06 269
Carolina Medical Products ANDA Approvals, 2002-06 273
Cedar Pharmaceuticals ANDA Approvals, 2002-06 274
Emerging Generic Companies Worldwide
CorePharma ANDA Approvals, 2002-06 276
Ferndale Laboratories ANDA Approvals, 2002-06 278
Fleming & Company Pharmaceuticals ANDA Approvals, 2002-06 279
Altana ANDA Approvals, 2002-06 280
G&W Laboratories ANDA Approvals, 2002-06 283
Glades Pharmaceuticals ANDA Approvals, 2002-06 284
GC Hanford Manufacturing ANDA Approvals, 2002-06 285
Harmony Labs ANDA Approvals, 2002-06 286
Hi-Tech Pharmacal ANDA Approvals, 2002-06 287
Impax Laboratories ANDA Approvals, 2002-06 292
Interpharm ANDA Approvals, 2002-06 301
InvaGen Pharmaceuticals ANDA Approvals, 2002-06 305
KUDCo ANDA Approvals, 2002-06 307
KV Pharmaceuticals / Ethex ANDA Approvals, 2002-06 309
Luitpold Pharmaceuticals ANDA Approvals, 2002-06 313
Lyne Laboratories ANDA Approvals, 2002-06 315
Mallinckrodt ANDA Approvals, 2002-06 316
Mikart ANDA Approvals, 2002-06 318
Morton Grove Pharmaceuticals ANDA Approvals, 2002-06 319
Neil Laboratories ANDA Approvals, 2002-06 321
Nephron Pharmaceuticals ANDA Approvals, 2002-06 322
Paddock Laboratories ANDA Approvals, 2002-06 323
Parenta Pharmaceuticals ANDA Approvals, 2002-06 324
Pharmaceutical Associates ANDA Approvals, 2002-06 326
Prometheus Laboratories ANDA Approvals, 2002-06 327
Roxane Laboratories ANDA Approvals, 2002-06 328
RxElite ANDA Approvals, 2002-06 330
Silarx Pharmaceuticals ANDA Approvals, 2002-06 331
Spear Pharmaceuticals ANDA Approvals, 2002-06 332
Spectrum Pharmaceuticals ANDA Approvals, 2002-06 333
Stiefel ANDA Approvals, 2002-06 338
SuperGen ANDA Approvals, 2002-06 339
Three Rivers ANDA Approvals, 2002-06 340
URL / Mutual ANDA Approvals, 2002-06 343
Upsher-Smith Laboratories ANDA Approvals, 2002-06 349
Vista Pharmaceuticals ANDA Approvals, 2002-06 355
VistaPharm ANDA Approvals, 2002-06 356
X-Gen Pharmaceuticals ANDA Approvals, 2002-06 357


Companies Mentioned 145 companies from 37 countries evaluated Abdi Ibrahim Abraxis BioScience Abrika Pharmaceuticals Ache Adcock Ingram Akorn Akrikhin Akyma Pharmaceuticals Alembic Alternova Amphastar Pharmaceuticals Andromaco Antibiotice Aurobindo Pharma Australian Pharmaceutical Industries Banner Pharmacaps Bedford Laboratories Belupo Bentley Pharmaceuticals Bestpharma Beximco Pharma Bilim Pharmaceuticals Biocon Biogaran Biolab Bio-nucleonics Pharma Biosano Biosintetica Biotika Boca Pharmacal Bryntsalov Calox Caraco Pharmaceutical Laboratories Carolina Medical Products Company CCL Cedar Pharmaceuticals Cedarburg Pharmaceuticals Cimed Cofasa Consilient Health Copyfarm CorePharma Cristalia Dr Raza Pharma Ecar EIPICo Elter EMS-Sigma Enaleni Pharmaceuticals ... Epla Labs Erka farm Eurand Eurofarma Europharm Farmacon Farmasa Farmindustria Ferndale Laboratories Fleming & Company Pharmaceuticals Fougera G&W Laboratories GeneMedix Genepharm Genfar Glades Pharmaceuticals Glenmark Pharmaceuticals Goldshield Grindeks Hamilton Laboratories Hanford Manufacturing Harmony Labs Highnoon Laboratories Hikma Hi-Tech Pharmacal Hovione FarmaCiencia Impax Laboratories Infarmasa Inno Biologics Interpharm Invagen Pharmaceuticals JB Chemicals & Pharmaceuticals Jubilant Organosys Kent Pharmaceuticals Kimia Kimiceg Kremers Urban Development Company KV Pharmaceutical La Sante Labopharm Laboratorios Kendrick Laboratorios Silanes Laboratorios Stein Lafrancol Leti Libbs Farmaceutica Luitpold Pharmaceuticals Lupin Laboratories Lyne Laboratories ... Mallinckrodt Matrix Laboratories Maver Medley Mepha Pharma Meyer Mikart Mintlab MN Pharmaceuticals Morton Grove Pharmaceuticals Natco Pharma Neil Laboratories Nephron Pharmaceuticals Orbus Orchid Chemicals & Pharmaceuticals Osmotica Pharmaceutical Paddock Laboratories Parenta Pharmaceuticals Pharmaceutical Associates Prometheus Laboratories ProStrakan Recip, ab Rosemont Pharmaceuticals Roxane Laboratories RxElite Sanitas Sigma Pharmaceuticals Silarx Pharmaceuticals Sopharma Spear Pharmaceuticals Spectrum Pharmaceuticals Spirig Stiefel Laboratories Streuli Strides Arcolab Sun Pharmaceutical Laboratories Supergen Tabuk Pharmaceutical Taro Pharmaceutical Industries Three Rivers Pharmaceuticals Unipharm United Research Laboratories/ Mutual Pharmaceutical Upsher-Smith Laboratories Veropharm Vista Pharmaceuticals Vistapharm X-Gen Pharmaceuticals


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/449291

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 21/08/2008 22:22:36
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Emerging Generic Drug Companies Worldwide 2007
Web Address:
http://www.researchandmarkets.com/reports/449291
Office Code:
OCHGFMQOPPU

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €895.00
Hard Copy €895.00 + EUR€ 50.00 Shipping/Handling *

* Shipping/Handling is only charged once per order.


Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646)607-1907 or (646)964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 21/08/2008 22:22:36

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646)607-1907 or (646)964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World